🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Research objective: To compare the efficacy and safety of Capox + Bev versu...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-02-01
Trial ID
NCT07383285
This is a prospective, non-randomized, single arm, single institution phase...
Status
Unknown
Location
Radiotherapy Oncology Centre "S.Maria" Hospital
Start Date
2016-12
Trial ID
NCT06207292
Treatments Being Tested
Anti-infective procedures play a very important role in the success of rege...
Status
Completed
Location
Gazi University, Faculty of Dentistry
Start Date
2018-01-01
Trial ID
NCT05447026
To explore the efficiency and safety of Tislelizumab combinated with carbop...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-04-20
Trial ID
NCT06366945
This is a prospective, single-arm, investigator-initiated clinical study (I...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-06
Trial ID
NCT07547332
Treatments Being Tested
This study evaluates the combination of stereotactic body radiation therapy...
Status
Terminated
Location
University of Virginia
Start Date
2014-11
Trial ID
NCT02284971
The REFINE study is evaluating whether a fluciclovine (18F) PET/CT scan can...
Status
Recruiting
Location
University Hospital Augsburg
Start Date
2025-03
Trial ID
NCT06859203
Knee osteoarthritis (OA) is the most common form of arthritis and the most ...
Status
Completed
Location
The University of Nottingham, City Hospital Campus
Start Date
2020-11-06
Trial ID
NCT04443452
Patients with salivary gland carcinoma were divided into groups according t...
Status
Recruiting
Location
Fei Ma
Start Date
2023-08-15
Trial ID
NCT06145308
Treatments Being Tested
To determine 2-year local (primary tumor site) control and toxicity rates i...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2014-02
Trial ID
NCT02159703
Treatments Being Tested